Shopping Cart
- Remove All
- Your shopping cart is currently empty
BZAD01 is a selective NMDA NR1A/2B receptor antagonist.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $39 | In Stock | |
5 mg | $77 | In Stock | |
10 mg | $127 | In Stock | |
25 mg | $255 | In Stock | |
50 mg | $397 | In Stock | |
100 mg | $658 | In Stock | |
200 mg | $919 | In Stock | |
1 mL x 10 mM (in DMSO) | $108 | In Stock |
Description | BZAD01 is a selective NMDA NR1A/2B receptor antagonist. |
In vivo | Parkinsonism was induced by microinjection of the toxin, 6-hydroxydopamine (6-OHDA) into the medial forebrain bundle (MFB) of 40 Sprague-Dawley rats. Parkinsonism and the efficacy of drugs were assessed using a battery of behavioural tests including balance beam, apomorphine-induced rotation, body axis bias or "curling", head position bias and disengage sensorimotor latency test. The main effects were that BZAD01 co-administration prevented chronic levodopa-induced potentiation of apomorphine rotation. However levodopa-treated rats were slower than either controls or BZAD-01-treated rats in the locomotor test[2]. |
Alias | BZAD-01, BZAD 01 |
Molecular Weight | 362.27 |
Formula | C16H12F6N2O |
Cas No. | 305339-41-7 |
Smiles | FC(F)(F)Oc1ccc(cc1)C(=N)NCc1ccccc1C(F)(F)F |
Relative Density. | 1.34 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 55 mg/ml (151.82 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.